Literature DB >> 17848749

Inhibition of glioma cell line A-172 MMP activity and cell invasion in vitro by a nutrient mixture.

M Waheed Roomi1, Vadim Ivanov, Tatiana Kalinovsky, Aleksandra Niedzwiecki, Matthias Rath.   

Abstract

Standard multimodality therapy of gliomas is associated with poor patient survival and significant toxicity. Abnormal expression of matrix metalloproteinases is associated with tumor growth and invasion. Based on reported antitumor properties, we investigated the effect of a combination of natural compounds (NM), primarily composed of lysine, proline, ascorbic acid, and green tea extract in vitro on glioma cell line A-172, by measuring MMP secretion, invasion through Matrigel, and cell proliferation. Glioma cells A-172 (ATCC) were grown in modified Dulbecco's Eagle medium with 10% fetal bovine serum and antibiotics and treated with NM at 0, 10, 50, 100, 500, and 1000 microg/mL concentration in triplicate at each dose. Cell proliferation was assayed by MTT, MMP secretion by zymography, invasion through Matrigel, and morphology by H&E staining. Zymography showed one band corresponding to MMP-2, which was inhibited by NM in a dose-dependent fashion, with virtual total inhibition at 500-microg/mL concentration. Invasion through Matrigel was completely inhibited at 1000 microg/mL NM. NM was not toxic to glioma cell line A-172 at lower concentrations and exhibited toxicity of 50% over the control at 1000 microg/mL. NM significantly inhibited MMP secretion and invasion-important parameters for cancer prevention, suggesting a possible therapeutic role.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17848749     DOI: 10.1007/bf02698045

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  41 in total

1.  Inhibitory effect of selenite on invasion of HT1080 tumor cells.

Authors:  S O Yoon; M M Kim; A S Chung
Journal:  J Biol Chem       Date:  2001-03-27       Impact factor: 5.157

2.  Effect of vitamin C on prostate cancer cells in vitro: effect on cell number, viability, and DNA synthesis.

Authors:  C Maramag; M Menon; K C Balaji; P G Reddy; S Laxmanan
Journal:  Prostate       Date:  1997-08-01       Impact factor: 4.104

3.  Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma.

Authors:  S R Bramhall; J P Neoptolemos; G W Stamp; N R Lemoine
Journal:  J Pathol       Date:  1997-07       Impact factor: 7.996

Review 4.  Second tumors after treatment of childhood malignancies.

Authors:  L L Robison; A Mertens
Journal:  Hematol Oncol Clin North Am       Date:  1993-04       Impact factor: 3.722

5.  Breast cancer and other second neoplasms after childhood Hodgkin's disease.

Authors:  S Bhatia; L L Robison; O Oberlin; M Greenberg; G Bunin; F Fossati-Bellani; A T Meadows
Journal:  N Engl J Med       Date:  1996-03-21       Impact factor: 91.245

6.  Matrix metalloproteinase-2 immunoreactive protein: a marker of aggressiveness in breast carcinoma.

Authors:  A Talvensaari-Mattila; P Pääkkö; M Höyhtyä; G Blanco-Sequeiros; T Turpeenniemi-Hujanen
Journal:  Cancer       Date:  1998-09-15       Impact factor: 6.860

7.  Forty-year experience with second malignancies after treatment of childhood cancer: analysis of outcome following the development of the second malignancy.

Authors:  M B Smith; H Xue; L Strong; H Takahashi; N Jaffe; H Ried; H Zietz; R J Andrassy
Journal:  J Pediatr Surg       Date:  1993-10       Impact factor: 2.545

8.  Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer.

Authors:  G I Murray; M E Duncan; P O'Neil; J A McKay; W T Melvin; J E Fothergill
Journal:  J Pathol       Date:  1998-07       Impact factor: 7.996

9.  Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood.

Authors:  B R O'Driscoll; P S Hasleton; P M Taylor; L W Poulter; H R Gattameneni; A A Woodcock
Journal:  N Engl J Med       Date:  1990-08-09       Impact factor: 91.245

10.  Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma.

Authors:  C F Sier; F J Kubben; S Ganesh; M M Heerding; G Griffioen; R Hanemaaijer; J H van Krieken; C B Lamers; H W Verspaget
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

View more
  6 in total

1.  Over-expression of ARHI decreases tumor growth, migration, and invasion in human glioma.

Authors:  Jing Chen; Songsheng Shi; Weizhong Yang; Chunmei Chen
Journal:  Med Oncol       Date:  2014-01-24       Impact factor: 3.064

2.  Recombinantly expressed MeICT, a new toxin from Mesobuthus eupeus scorpion, inhibits glioma cell proliferation and downregulates Annexin A2 and FOXM1 genes.

Authors:  Maryam Shahbazi Gandomkari; Hoda Ayat; Ali Mohammad Ahadi
Journal:  Biotechnol Lett       Date:  2022-05-07       Impact factor: 2.461

3.  Components of an anticancer diet: dietary recommendations, restrictions and supplements of the Bill Henderson Protocol.

Authors:  Cynthia Mannion; Stacey Page; Laurie Heilman Bell; Marja Verhoef
Journal:  Nutrients       Date:  2010-12-30       Impact factor: 5.717

4.  RNAi-mediated inhibition of MSP58 decreases tumour growth, migration and invasion in a human glioma cell line.

Authors:  Wei Lin; Jing Zhang; Jian Zhang; Xinping Liu; Zhou Fei; Xia Li; Laetitia Davidovic; Zhuo Tang; Lan Shen; Yanchun Deng; Angang Yang; Hua Han; Xiang Zhang; Libo Yao
Journal:  J Cell Mol Med       Date:  2009 Nov-Dec       Impact factor: 5.310

5.  Chlorotoxin Fused to IgG-Fc Inhibits Glioblastoma Cell Motility via Receptor-Mediated Endocytosis.

Authors:  Tomonari Kasai; Keisuke Nakamura; Arun Vaidyanath; Ling Chen; Sreeja Sekhar; Samah El-Ghlban; Masashi Okada; Akifumi Mizutani; Takayuki Kudoh; Hiroshi Murakami; Masaharu Seno
Journal:  J Drug Deliv       Date:  2012-12-05

6.  Chlorotoxin-Fc fusion inhibits release of MMP-2 from pancreatic cancer cells.

Authors:  Samah El-Ghlban; Tomonari Kasai; Tsukasa Shigehiro; Hong Xia Yin; Sreeja Sekhar; Mikiko Ida; Anna Sanchez; Akifumi Mizutani; Takayuki Kudoh; Hiroshi Murakami; Masaharu Seno
Journal:  Biomed Res Int       Date:  2014-01-06       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.